Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicriviroc in treatment-experienced HIV (VICTOR-E1)
NCT00243230Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vicriviroc in human immunodeficiency virus infection (HIV), sponsored by Merck & Co.. Started Sep 2005; status: completed.
02
Drugs
vicriviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00243230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243230.